label dose escalation

Related by string. * labels . labeled . Labels . labeling : Multi Protocol Label . label Def Jam . Multiprotocol Label Switching MPLS . origin labeling / Doses . DOSE . DO Se . DOSES : mg kg dose . tolerated dose MTD . multiple ascending dose . priming doses / escalations . Escalation . Escalations . ESCALATION : dose escalation study . dose escalation trial . dose escalation . dose escalation clinical * *

Related by context. Frequent words. (Click for all words.) 72 dose escalation study 72 dose escalation trial 67 placebo controlled 67 blind randomized placebo 66 randomized placebo controlled 66 multicenter randomized double 66 Phase Ib 66 multicenter 65 Phase 1b 65 Phase 2a clinical 65 randomized controlled 64 pivotal Phase 64 prospective randomized 63 tolerated dose MTD 63 blind randomized 63 phase IIb 63 dose escalation 63 safety tolerability 63 double blind placebo 63 blind placebo controlled 63 Phase 2a 62 Phase 1b clinical 62 randomized double 62 Phase IIa trial 62 Phase 2b trial 62 Phase 2a trial 62 randomized #:# 62 randomized 62 Phase 2b study 62 randomized Phase 62 Phase 2b clinical 61 Phase IIa 61 Phase IIb trial 61 HGS ETR1 60 multiple ascending dose 60 pharmacodynamics 60 Phase III pivotal 60 pivotal Phase III 60 randomized controlled clinical 60 Phase IIa clinical 60 single ascending dose 60 Phase III clinical 59 randomized clinical 59 investigational oral 58 tolerability 58 confirmatory Phase 3 58 Phase IIb clinical 58 phase 2a 58 Phase 2b 58 RG# [001] 57 Phase IIb 57 pharmacokinetics 57 dose limiting toxicities 57 unblinded 57 BAY #-# 57 PF # [001] 57 relapsing remitting multiple sclerosis 56 Perifosine 56 CA4P 56 dosing regimens 55 clinical trial 55 blinatumomab 55 LEVADEX 55 CYT# 55 Phase III 55 refractory multiple myeloma 55 investigational drug 54 AP# [003] 54 eculizumab 54 multicenter study 54 ACTEMRA 54 pharmacokinetic 54 Phase II 54 Azixa 54 Investigational Device Exemption IDE 54 mg BID 54 denufosol 53 Initiates Phase 53 NGX# 53 ZYBRESTAT 53 Phase III clinical trials 53 Atiprimod 53 INCB# [002] 53 IMGN# 53 VEGF Trap 53 cutaneous T cell 53 PRX # 53 tgAAC# 53 sapacitabine 52 pharmacodynamic 52 investigational compound 52 evaluable patients 52 Randomized 52 pharmacokinetic profile 52 orally administered 52 ocular hypertension 52 PMX # 52 humanized monoclonal antibody 52 pralatrexate 52 placebo controlled trials 52 certolizumab pegol

Back to home page